
Health Dictionary
Reliable, easy-to-read patient information on common medical conditions β written in plain language, free of jargon, and grounded in current evidence. Browse the most frequent diagnoses, understand what they mean for everyday life, and learn which steps and questions help you have a focused conversation with your doctor.
Esophagitis laboratory findings
Introduction
Overview
Overview
A complete blood count (CBC) is performed in patients with neutropenia or who are immunosuppressed. A CD4 count and HIV test are performed in patients with risk factors for HIV. A collagen workup (eg, antinuclear antibody [ANA], anti-dsDNA) may be performed based on the underlying disease.
Laboratory Findings
Laboratory Findings
Eosinophilic Esophagitis
Laboratory findings of the EoE are as follows:[1][2][3][4][5][6]
- There are no specific diagnostic markers to diagnose EoE patients.
- Although not specific, elevated serum IgE level is identified in majority patients.
- Increased peripheral eosinophil count is also seen in the majority of patients.
- There are 3 main ways in which food allergies can be detected in EoE are as follows:
| Test | Procedure | Interpretation |
|---|---|---|
| Skin prick testing | A small amount of allergen is introduced into the skin of the patient through a gentle puncture with a pricking device. |
|
| Atopy patch testing |
|
|
Reflux Esophagitis
Ambulatory reflux monitoring
- GERD is mostly diagnosed clinically by the presenting typical symptoms which include heartburn, regurgitation, and dysphagia.
- Correlation of the GERD symptoms with confirmed acid presence by the ambulatory reflux monitoring is strongly suggestive of GERD.
- Ambulatory reflux monitoring is recommended by the American College of Gastroenterology (ACG) as the only laboratory test to determine the presence of acidic reflux in the esophagus.[7]
- Indications of ambulatory reflux monitoring include the following:[8]
- Ambulatory reflux monitoring is performed in either two ways which include:
- Telemetry capsule (48 hours monitoring)
- Transnasal catheter (24 hours monitoring)
References
References
- β Roy-Ghanta S, Larosa DF, Katzka DA (2008). “Atopic characteristics of adult patients with eosinophilic esophagitis”. Clin. Gastroenterol. Hepatol. 6 (5): 531β5. doi:10.1016/j.cgh.2007.12.045. PMIDΒ 18304887.
- β Erwin EA, James HR, Gutekunst HM, Russo JM, Kelleher KJ, Platts-Mills TA (2010). “Serum IgE measurement and detection of food allergy in pediatric patients with eosinophilic esophagitis”. Ann. Allergy Asthma Immunol. 104 (6): 496β502. doi:10.1016/j.anai.2010.03.018. PMIDΒ 20568382.
- β Dellon ES, Gibbs WB, Fritchie KJ, Rubinas TC, Wilson LA, Woosley JT, Shaheen NJ (2009). “Clinical, endoscopic, and histologic findings distinguish eosinophilic esophagitis from gastroesophageal reflux disease”. Clin. Gastroenterol. Hepatol. 7 (12): 1305β13, quiz 1261. doi:10.1016/j.cgh.2009.08.030. PMIDΒ 19733260.
- β Chehade M, Sampson HA (2008). “Epidemiology and etiology of eosinophilic esophagitis”. Gastrointest. Endosc. Clin. N. Am. 18 (1): 33β44, viii. doi:10.1016/j.giec.2007.09.002. PMIDΒ 18061100.
- β Dellon ES, Aderoju A, Woosley JT, Sandler RS, Shaheen NJ (2007). “Variability in diagnostic criteria for eosinophilic esophagitis: a systematic review”. Am. J. Gastroenterol. 102 (10): 2300β13. doi:10.1111/j.1572-0241.2007.01396.x. PMIDΒ 17617209.
- β Aceves SS, Newbury RO, Dohil R, Schwimmer J, Bastian JF (2007). “Distinguishing eosinophilic esophagitis in pediatric patients: clinical, endoscopic, and histologic features of an emerging disorder”. J. Clin. Gastroenterol. 41 (3): 252β6. doi:10.1097/01.mcg.0000212639.52359.f1. PMIDΒ 17426462.
- β Katz PO, Gerson LB, Vela MF (2013). “Guidelines for the diagnosis and management of gastroesophageal reflux disease”. Am J Gastroenterol. 108 (3): 308β28, quiz 329. doi:10.1038/ajg.2012.444. PMIDΒ 23419381.
- β Katz PO, Gerson LB, Vela MF (2013). “Guidelines for the diagnosis and management of gastroesophageal reflux disease”. Am J Gastroenterol. 108 (3): 308β28, quiz 329. doi:10.1038/ajg.2012.444. PMIDΒ 23419381.
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1] Associate Editor(s)-in-Chief: Ajay Gade MD[2]]
